Crisaborole safe for long-term treatment of atopic dermatitis

October 11, 2017

(HealthDay)—Crisaborole ointment appears to be safe for the long-term treatment of atopic dermatitis (AD), according to a study published in the October issue of the Journal of the American Academy of Dermatology.

Lawrence F. Eichenfield, M.D., from Rady Children's Hospital in San Diego, and colleagues assessed the long-term safety results from a multicenter, open-label, 48-week safety study of 517 ≥2 years of age with mild to moderate AD who continued crisaborole treatment after completing a 28-day phase 3 pivotal study.

The researchers found that during the pivotal study and the open-label trial, 65 percent of patients reported at least one treatment-emergent adverse event (TEAE), most of which were mild (51.2 percent) or moderate (44.6 percent) and considered unrelated to treatment (93.1 percent). There was consistency with regard to the frequency and severity of TEAEs. Overall, treatment-related AEs were reported in 10.2 percent of patients and most commonly included dermatitis atopic (3.1 percent), application-site pain (2.3 percent), and application-site infection (1.2 percent). Because of TEAEs, nine patients (1.7 percent) discontinued the long-term study.

"Crisaborole ointment had a low frequency of treatment-related AEs over 48 weeks of of patients with AD," conclude the authors.

Several authors disclosed financial ties to the pharmaceutical industry, including Anacor Pharmaceuticals, which funded the study.

Explore further: Secukinumab effective for moderate / severe scalp psoriasis

More information: Abstract/Full Text

Related Stories

Secukinumab effective for moderate / severe scalp psoriasis

September 29, 2017
(HealthDay)—Secukinumab is safe and effective as a treatment for patients with extensive moderate-to-severe scalp psoriasis, according to a study published in the October issue of the Journal of the American Academy of ...

IgE allergy testing improves atopic dermatitis outcomes

July 6, 2017
(HealthDay)—Identification of allergens by immunoglobulin E (IgE) testing improves outcomes in atopic dermatitis, according to a study published online June 20 in the International Journal of Dermatology.

Human breast milk effective for atopic dermatitis in infants

July 25, 2015
(HealthDay)—Topical application of human breast milk (HBM) is effective for infants with mild to moderate atopic dermatitis, according to a study published in the August issue of the International Journal of Dermatology.

Systemic corticosteroids discouraged for atopic dermatitis

September 26, 2017
(HealthDay)—Routine use of systemic corticosteroids is generally discouraged for atopic dermatitis, according to research published online Sept. 2 in the British Journal of Dermatology.

Dupilumab effective in atopic dermatitis

October 4, 2016
(HealthDay)—Dupilumab is effective for patients with moderate-to-severe atopic dermatitis that is inadequately controlled by topical treatment, according to a study published online Oct. 1 in the New England Journal of ...

Efficacy of wet wrap therapy for atopic dermatitis undetermined

November 14, 2016
(HealthDay)—Evidence that wet wrap therapy (WWT) is more effective than topical steroids for the treatment of atopic dermatitis is mixed, according to a review published online Nov. 8 in the British Journal of Dermatology.

Recommended for you

New insights into herpes virus could inform vaccine development

October 18, 2017
A team of scientists has discovered new insights into the mechanisms of Epstein-Barr virus (EBV) infection, as well as two antibodies that block the virus' entry into cells. The findings, published in Proceedings of the National ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.